-
Something wrong with this record ?
Genotoxic changes in peripheral lymphocytes after therapeutic exposure to crude coal tar and ultraviolet radiation
A. Malkova, R. Kohlerova, Z. Fiala, K. Hamakova, I. Selke-Krulichova, L. Borska
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
27283756
DOI
10.5507/bp.2016.032
Knihovny.cz E-resources
- MeSH
- Chromosome Aberrations drug effects radiation effects MeSH
- Chronic Disease MeSH
- Coal Tar adverse effects MeSH
- Adult MeSH
- DNA Breaks, Double-Stranded drug effects radiation effects MeSH
- Keratolytic Agents adverse effects MeSH
- Middle Aged MeSH
- Humans MeSH
- Lymphocytes * MeSH
- Psoriasis therapy MeSH
- Aged MeSH
- Ultraviolet Therapy adverse effects MeSH
- Ultraviolet Rays adverse effects MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
AIMS: Goeckerman therapy is based on combined exposure to UV radiation (UVA, UVB) and crude coal tar (PAHs). Some indicators suggest a genotoxic hazard, however, the level of genotoxic risk of the therapy has not yet been investigated sufficiently. This study aims to assesss the genotoxic risk. METHODS: The studied group consisted of patients with chronic stable plaque psoriasis treated by Goeckerman therapy (n = 29). Heparin-treated peripheral blood samples were collected one day before the first treatment and immediately after the last procedure. The lymphocytes were isolated from the blood. The level of genotoxicity was evaluated using an alkaline version of the Comet assay which detects DNA single strand breaks (DNA-SSBs), a neutral version of the Comet assay which detects DNA double strand breaks (DNA-DSBs), and using chromosomal aberrations. RESULTS: The level of DNA-SSBs increased insignificantly (median; Q1-Q3): 1.4 (0.4; 0.1-1.4) vs. 2.5 (0.6; 0.3-2.7) %tDNA (P = 0.11) and the level of DNA-DSBs increased significantly: 7.8 (6.5; 3.4-10.5) vs. 20.7 (19.3; 14.2-24.6) % DNA (P < 0.001). The total number of aberrated cells (P < 0.001) and structurally aberrated cells (P < 0.001) increased significantly. CONCLUSION: The elevated levels of the DNA-DSBs and the chromosomal aberrations in the peripheral lymphocytes indicated a genotoxic hazard. However, the elevated level of the chromosomal abnormalities was below the upper level of the reference range for healthy Czech adults. While, the genotoxic risk appears to be low, Goeckerman treatment represents a further contribution to the lifetime load of genotoxic factors.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17016697
- 003
- CZ-PrNML
- 005
- 20170519133915.0
- 007
- ta
- 008
- 170516s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2016.032 $2 doi
- 035 __
- $a (PubMed)27283756
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Malkova, Andrea $u Department of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic
- 245 10
- $a Genotoxic changes in peripheral lymphocytes after therapeutic exposure to crude coal tar and ultraviolet radiation / $c A. Malkova, R. Kohlerova, Z. Fiala, K. Hamakova, I. Selke-Krulichova, L. Borska
- 520 9_
- $a AIMS: Goeckerman therapy is based on combined exposure to UV radiation (UVA, UVB) and crude coal tar (PAHs). Some indicators suggest a genotoxic hazard, however, the level of genotoxic risk of the therapy has not yet been investigated sufficiently. This study aims to assesss the genotoxic risk. METHODS: The studied group consisted of patients with chronic stable plaque psoriasis treated by Goeckerman therapy (n = 29). Heparin-treated peripheral blood samples were collected one day before the first treatment and immediately after the last procedure. The lymphocytes were isolated from the blood. The level of genotoxicity was evaluated using an alkaline version of the Comet assay which detects DNA single strand breaks (DNA-SSBs), a neutral version of the Comet assay which detects DNA double strand breaks (DNA-DSBs), and using chromosomal aberrations. RESULTS: The level of DNA-SSBs increased insignificantly (median; Q1-Q3): 1.4 (0.4; 0.1-1.4) vs. 2.5 (0.6; 0.3-2.7) %tDNA (P = 0.11) and the level of DNA-DSBs increased significantly: 7.8 (6.5; 3.4-10.5) vs. 20.7 (19.3; 14.2-24.6) % DNA (P < 0.001). The total number of aberrated cells (P < 0.001) and structurally aberrated cells (P < 0.001) increased significantly. CONCLUSION: The elevated levels of the DNA-DSBs and the chromosomal aberrations in the peripheral lymphocytes indicated a genotoxic hazard. However, the elevated level of the chromosomal abnormalities was below the upper level of the reference range for healthy Czech adults. While, the genotoxic risk appears to be low, Goeckerman treatment represents a further contribution to the lifetime load of genotoxic factors.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a chromozomální aberace $x účinky léků $x účinky záření $7 D002869
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a dehet uhelný $x škodlivé účinky $7 D003033
- 650 _2
- $a dvouřetězcové zlomy DNA $x účinky léků $x účinky záření $7 D053903
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a keratolytika $x škodlivé účinky $7 D007641
- 650 12
- $a lymfocyty $7 D008214
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a psoriáza $x terapie $7 D011565
- 650 _2
- $a ultrafialové záření $x škodlivé účinky $7 D014466
- 650 _2
- $a terapie ultrafialovými paprsky $x škodlivé účinky $7 D014467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kohlerova, Renata $u Department of Medical Biochemistry, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic
- 700 1_
- $a Fiala, Zdeněk, $u Department of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic $d 1955- $7 nlk19990073147
- 700 1_
- $a Hamáková, Květoslava $u Clinic of Dermal and Venereal Disease, University Hospital Hradec Kralove, Czech Republic $7 xx0064204
- 700 1_
- $a Selke Krulichová, Iva, $u Department of Medical Biophysic, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic $d 1970- $7 xx0076216
- 700 1_
- $a Borská, Lenka $u Department of Pathological Physiology, Faculty of Medicine in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic $7 nlk20060173900
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 4 (2016), s. 553-558
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170516 $b ABA008
- 991 __
- $a 20170517133906 $b ABA008
- 999 __
- $a ok $b bmc $g 1205837 $s 977506
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 160 $c 4 $d 553-558 $e 20160609 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20170516